State Street Corp Pro Qr Therapeutics N.V. Transaction History

State Street Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.56 - $1.0 $82,059 - $146,534	-146,534 Reduced 73.76%	52,123 $41,000
Q1 2022 May 16, 2022	BUY	$0.9 - $8.39 $6,903 - $64,351	7,670 Added 4.02%	198,657 $180,000
Q4 2021 Feb 14, 2022	BUY	$6.58 - $8.44 $611,374 - $784,194	92,914 Added 94.74%	190,987 $1.53 Million
Q3 2021 Nov 15, 2021	BUY	$5.16 - $8.47 $127,968 - $210,056	24,800 Added 33.85%	98,073 $821,000
Q2 2021 Aug 16, 2021	BUY	$5.75 - $7.59 $421,319 - $556,142	73,273 New	73,273 $494,000
Q4 2020 Feb 16, 2021	SELL	$3.58 - $4.85 $36,104 - $48,912	-10,085 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$4.79 - $6.3 $1,920 - $2,526	-401 Reduced 3.82%	10,085 $48,000
Q2 2020 Aug 14, 2020	SELL	$4.5 - $6.53 $2,430 - $3,526	-540 Reduced 4.9%	10,486 $64,000
Q1 2020 May 11, 2020	BUY	$5.25 - $9.9 $57,886 - $109,157	11,026 New	11,026 $61,000

17.4M

37.7K

21.3K

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $144M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.